A joint research project between Hiroshima University and Kewpie Corporation has confirmed the safety of chicken eggs (allergy-reduced eggs) that do not contain ovomucoid, a major allergen, which was successfully created by genome editing using our technology "Platinum TALEN".
This joint research is being conducted as part of a full-scale, 10-year project under the JST Support Program for Formation of Co-Creation Opportunities (COI-NEXT), which started in April 2022. The study’s findings will be published in the May 2023 issue of the journal Food and Chemical Toxicology.
For more information, please visit the following URL!
<Reference link>
- Kewpie News Release *Japanese only
- Hiroshima University Press Release *Japanese only